{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T17:27:30Z","timestamp":1769189250529,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2023\/004226"],"award-info":[{"award-number":["CRG\/2023\/004226"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bmc.2025.118527","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T08:36:57Z","timestamp":1766047017000},"page":"118527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of 2-amino-1,3,4-thiadiazoles as new potential EGFR inhibitors for treatment of cancer"],"prefix":"10.1016","volume":"134","author":[{"given":"Sachin M.","family":"Thorat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summon","family":"Koul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Kote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramakrishna G.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118527_bb0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejmech.2018.11.076","article-title":"CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors","volume":"164","author":"Xi","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmech.2016.09.099","article-title":"Design, synthesis and cytotoxic activity of certain novel chalcone analogous compounds","volume":"126","author":"El-Meligie","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0020","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmc.2025.118527_bb0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.semcancer.2008.03.012","article-title":"Theories of carcinogenesis: an emerging perspective","volume":"18","author":"Sonnenschein","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bmc.2025.118527_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/msb4100014","article-title":"A comprehensive pathway map of epidermal growth factor receptor signalling","volume":"1","author":"Oda","year":"2005","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.bmc.2025.118527_bb0035","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1110\/ps.052045306","article-title":"Structure and dynamics of the epidermal growth factor receptor C-terminal phosphorylation domain","volume":"15","author":"Lee","year":"2006","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmc.2025.118527_bb0040","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.18632\/oncotarget.6461","article-title":"Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2025.118527_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol Oncol"},{"key":"10.1016\/j.bmc.2025.118527_bb0050","first-page":"S19","article-title":"Epidermal growth factor receptor as a target for chemotherapy","volume":"5","author":"Vallb\u00f6hmer","year":"2005","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.bmc.2025.118527_bb0055","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.3390\/molecules26216677","article-title":"Globally approved EGFR inhibitors: insights into their syntheses, target kinases, biological activities, receptor interactions, and metabolism","volume":"26","author":"Abourehab","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118527_bb0060","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/1389557515666150519104057","article-title":"Biological and pharmacological activities of 1,3,4-thiadiazole based compounds","volume":"15","author":"Matysiak","year":"2015","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0065","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/ph18040580","article-title":"Recent developments of 1,3,4-thiadiazole compounds as anticancer agents","volume":"18","author":"Indelicato","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2025.118527_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200355","article-title":"1, 3, 4-Thiadiazole and 1, 2, 4-triazole-5-thione derivatives bearing 2-pentyl-5-phenyl-2, 4-dihydro-3H-1, 2, 4-triazole 3-one ring: synthesis, molecular docking, urease inhibition, and crystal structure","volume":"356","author":"G\u00fcltekin","year":"2023","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2025.118527_bb0075","doi-asserted-by":"crossref","first-page":"15810","DOI":"10.1039\/D3RA02716C","article-title":"New 1, 3, 4-thiadiazoles as potential anticancer agents: pro-apoptotic, cell cycle arrest, molecular modelling, and ADMET profile","volume":"13","author":"Hekal","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118527_bb0080","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.3390\/molecules27196368","article-title":"Synthesis, molecular docking study, and cytotoxicity evaluation of some novel 1,3,4-thiadiazole as well as 1,3-thiazole derivatives bearing a pyridine moiety","volume":"27","author":"Abouzied","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118527_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105469","article-title":"Discovery of N-(1,3,4-thiadiazol-2-yl) benzamide derivatives containing a 6,7-methoxyquinoline structure as novel EGFR\/HER-2 dual-target inhibitors against cancer growth and angiogenesis","volume":"119","author":"Li","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104794","article-title":"Development of adamantane scaffold containing 1, 3, 4-thiadiazole derivatives: design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR","volume":"110","author":"Wassel","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70035","article-title":"Design, synthesis, biological evaluation and molecular docking study of new 1,3,4-thiadiazole-based compounds as EGFR inhibitors","volume":"86","author":"Serag","year":"2025","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2025.118527_bb0100","doi-asserted-by":"crossref","first-page":"31500","DOI":"10.1021\/acsomega.3c04635","article-title":"Synthesis and anticancer activities of pyrazole\u2013thiadiazole-based EGFR inhibitors","volume":"8","author":"Kurban","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2025.118527_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-025-11259-7","article-title":"Design, synthesis and antitumor activity of thiadiazole derivatives as novel ALK kinase inhibitors","author":"Huo","year":"2025","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmc.2025.118527_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70097","article-title":"New 1,3,4-thiadiazole-based dual B-Raf\/VEGFR-2 inhibitors with potential anti-breast activity: design, synthesis, in vitro and in silico evaluations","volume":"358","author":"Elgammal","year":"2025","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2025.118527_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.143544","article-title":"Development of new thiadiazole-based compounds targeting VEGFR-2: in vitro anticancer evaluation, mechanistic investigations, and in silico studies","volume":"1348","author":"Alsfouk","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118527_bb0120","first-page":"915","article-title":"Design and synthesis of thiadiazoles as anticancer, apoptotic, and VEGFR-2 inhibitors, future","volume":"17","author":"Elgammal","year":"2025","journal-title":"Med Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108197","article-title":"Fragment-based drug discovery: small fragments, big impact \u2212 success stories of approved oncology therapeutics","volume":"156","author":"Khedkar","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0130","article-title":"Computational design, synthesis, and bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide derivatives: dual inhibition of EGFRWT and EGFRT790M with ADMET profiling","volume":"143","author":"Khedkar","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0135","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1039\/D1QO00168J","article-title":"Electrochemical oxidative synthesis of 1,3,4-thiadiazoles from isothiocyanates and hydrazones","volume":"8","author":"Ma","year":"2021","journal-title":"Org Chem Front"},{"key":"10.1016\/j.bmc.2025.118527_bb0140","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/cctc.201500304","article-title":"Photoredox catalysis of intramolecular cyclizations with a reusable silica-bound ruthenium complex","volume":"7","author":"Barbante","year":"2015","journal-title":"ChemCatChem"},{"key":"10.1016\/j.bmc.2025.118527_bb0145","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1021\/acs.joc.3c00320","article-title":"Chemodivergent photocatalyzed heterocyclization of hydrazones and isothiocyanates for the selectivity synthesis of 2-amino-1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones","volume":"88","author":"Teng","year":"2023","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/ajoc.202500386","article-title":"Visible-light photoredox catalyzed facile synthesis of 2-amino-1,3,4-thiadiazoles from aldehydes and thiosemicarbazides","author":"Thorat","year":"2025","journal-title":"Asian J Org Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0155","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.3390\/cells10123327","article-title":"Regulation of cell cycle progression by growth factor-induced cell signalling","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2025.118527_bb0160","doi-asserted-by":"crossref","first-page":"28.6.1","DOI":"10.1002\/0471142727.mb2806s111","article-title":"Assaying cell cycle status using flow cytometry","volume":"111","author":"Kim","year":"2015","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.bmc.2025.118527_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33665","article-title":"Flow cytometry-based quantitative analysis of cellular protein expression in apoptosis subpopulations: a protocol","volume":"10","author":"Alshehade","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bmc.2025.118527_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yexcr.2017.04.016","article-title":"EGFR-mediated apoptosis via STAT3","volume":"356","author":"Jackson","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bmc.2025.118527_bb0175","first-page":"5160","article-title":"Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer","volume":"12","author":"Huether","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bmc.2025.118527_bb0180","first-page":"4838","article-title":"Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase","volume":"57","author":"Moyer","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2025.118527_bb0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/BST20110609","article-title":"Cross-talk between mitogenic Ras\/MAPK and survival PI3K\/Akt pathways: a fine balance","volume":"40","author":"Aksamitiene","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bmc.2025.118527_bb0190","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bmc.2025.118527_bb0195","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2005.02.040","article-title":"Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics","volume":"43","author":"Huether","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.bmc.2025.118527_bb0200","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/acs.jctc.1c00136","article-title":"Reliable and accurate solution to the induced fit docking problem for protein\u2013ligand binding","volume":"17","author":"Miller","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2025.118527_bb0205","first-page":"14","article-title":"Swiss ADME and pkCSM webservers predictors: an integrated online platform for accurate and comprehensive predictions for in silico ADME\/T properties of artemisinin and its derivatives","volume":"325","author":"AL Azzam","year":"2022","journal-title":"Compl Use of Min Resour"},{"key":"10.1016\/j.bmc.2025.118527_bb0210","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2025.118527_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108861","article-title":"Chalcone-inspired indole, carbazole, and phenothiazine hybrids as potent aldose reductase inhibitors with selective anticancer potential: rational design, synthesis, and multi-level characterization","volume":"164","author":"G\u00fcle\u00e7","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108788","article-title":"N-substituted phthalimide\u2013carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: synthesis, mechanistic insights, and cancer-relevant profiling","volume":"163","author":"Zognjani","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118416","article-title":"Phthalimide\u2013benzoic acid hybrids as potent aldose reductase inhibitors: synthesis, enzymatic kinetics, and in silico characterization","volume":"131","author":"Hoti","year":"2025","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0235","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/D4MD00617H","article-title":"Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity","volume":"16","author":"Buza","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0240","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/14756366.2022.2135512","article-title":"Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFRWT and EGFRT790M inhibitors","volume":"38","author":"Al-Warhi","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2025.118527_bb0245","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nprot.2013.011","article-title":"Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle","volume":"8","author":"Rosner","year":"2013","journal-title":"Nat Protoc"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:33:15Z","timestamp":1769117595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625004699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":48,"alternative-id":["S0968089625004699"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118527","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of 2-amino-1,3,4-thiadiazoles as new potential EGFR inhibitors for treatment of cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118527"}}